Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)
GABY
International, Multi Centre, Open, Prospective, Randomized Study: Banded Versus Conventional Laparoscopic Roux-en-Y (GABY)
2 other identifiers
interventional
384
7 countries
14
Brief Summary
Banded Versus Conventional Laparoscopic Roux-en-Y Gastric Bypass (GABY). The aim of this novel study is to evaluate, if an additional restrictive silastic ring can avoid dilation of the gastro-entero anastomosis and adjacent small bowel with consecutive better postoperative weight loss and significantly improved long-term weight maintenance. The study will not investigate the GaBP-Ring as medical product but the effect of the GaBP-Ring on weight loss in comparison to gastric bypass alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2009
Longer than P75 for phase_4
14 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 17, 2009
CompletedFirst Posted
Study publicly available on registry
November 18, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFebruary 17, 2011
February 1, 2011
5.1 years
November 17, 2009
February 16, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative reduction of body mass index (BMI) and maintenance related to used bariatric procedure
0, 3, 6, 12 months and 2, 3, 4, 5 years
Study Arms (2)
Group A
ACTIVE COMPARATORConventional laparoscopic Roux-en-Y gastric bypass (Golden Standard)
Group B
EXPERIMENTALConventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring
Interventions
Conventional laparoscopic Roux-en-Y gastric bypass
conventional laparoscopic Roux-en-Y gastric bypass with additional restrictive silastic ring (GaBP-Ring)
Eligibility Criteria
You may qualify if:
- BMI ≥ 40 kg /m2 to ≤ 50 kg/m2
- Eating habit: sweet eater and volume eater
- Signed informed consent
- Patients with one or more of the following comorbidities: Hypertension, Diabetes mellitus Type 2, Hyperlipidemia, Hyperuricemia, Sleep apnea, Degenerative diseases of: Spine osteochondrosis, hip, knee, feet
You may not qualify if:
- History of obesity surgery
- History of major abdominal surgery with consecutive malabsorption (no resections of the stomach, small and large bowel (exception: appendectomy)
- Patients not eligible to implement silastic ring size 6.5 cm
- History of drug or alcohol abuse
- History of major psychiatric illness conflicting with patient's compliance
- History of recent or chronic steroid medication
- Autoimmune disease
- Inflammatory bowel disease or malabsorptive disease
- Liver cirrhosis (CHILD B + C)
- Active viral or bacterial disease (e.g. HIV, Hepatitis B or C, Tbc etc.)
- Pregnant women or women with childbearing potential without efficient contraception
- History of cancer in the last five years
- Need of long-term anticoagulant medication for any reason
- Any medication with ingredient ASA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ClinTrio Ltd.lead
Study Sites (14)
Hospital Hallein (Scientific Review Board)
Hallein, 5400, Austria
Hospital AZ St.-Jan AV
Bruges, 8000, Belgium
AZ Sint-Blasius
Dendermonde, 9200, Belgium
AZ Nikolaas
Sint-Niklaas, 9100, Belgium
Privatpraxis Chirurgie bei Schlossparkklinik
Berlin, 14059, Germany
Albert-Ludwigs-University
Freiburg im Breisgau, 79106, Germany
Universitätsklinikum Hamburg-Eppendorf (UKE)
Hamburg, 20246, Germany
Chirurgische Klinik München-Bogenhausen GmbH
München, 81679, Germany
Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
Villingen-Schwenningen, 78011, Germany
Atruim Medical Centre
Heerlen, 6401, Netherlands
Medical University of Lodz
Lodz, 90-152, Poland
Centro Hospitalar de Lisboa Central
Lisbon, 1150-199, Portugal
Hospital de Sao Sebastiano
Santa Maria de Feira, 4520-211, Portugal
International Medical Center
Jeddah, 2172, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Konrad W Karcz, MD
Albert-Ludwigs-University of Freiburg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 17, 2009
First Posted
November 18, 2009
Study Start
February 1, 2009
Primary Completion
March 1, 2014
Study Completion
March 1, 2015
Last Updated
February 17, 2011
Record last verified: 2011-02